United States · FDA National Drug Code directory
Orladeyo
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72769-101_3235d554-689b-47e6-9b28-032b051423e2
- Product NDC
- 72769-101
- Form
- CAPSULE
- Composition / generic term
- Berotralstat hydrochloride
- Labeler
- BioCryst Pharmaceuticals, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20201204
- Source listing expiry
- 20271231
Source-listed ingredients
- BEROTRALSTAT HYDROCHLORIDE — 150 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 4 DOSE PACK in 1 CARTON (72769-101-01) / 1 BLISTER PACK in 1 DOSE PACK / 7 CAPSULE in 1 BLISTER PACK · 72769-101-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →